• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IL-22R1 在炎症中的新型驱动作用

A novel role for IL-22R1 as a driver of inflammation.

机构信息

Cancer and Inflammation Program, Center for Cancer Research, Frederick, MD, USA.

出版信息

Blood. 2011 Jan 13;117(2):575-84. doi: 10.1182/blood-2010-05-285908. Epub 2010 Oct 22.

DOI:10.1182/blood-2010-05-285908
PMID:20971950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3031481/
Abstract

The interleukin (IL)-22R1 chain of the heterodimeric IL-22 receptor is not expressed on normal leukocytes, but this receptor is expressed on T cells from anaplastic lymphoma kinase-positive (ALK(+)) anaplastic large cell lymphoma (ALCL) patients. To investigate the consequences of aberrant expression of this receptor on lymphocytes, we generated transgenic mice that express IL-22R1 on lymphocytes. The health of these animals progressively deteriorated at 8 to 12 weeks of age, as they displayed respiratory distress, rough coat and sluggish movement, and subsequent lethality due to multiorgan inflammation. The IL-22R1 transgenic animals developed neutrophilia that correlated with increased levels of circulating IL-17 and granulocyte colony-stimulating factor. In addition, these mice had increased serum IL-22 levels, suggesting that T cells expressing IL-22R1 generate IL-22 in a positive autoregulatory loop. As a result of the mouse model findings, we analyzed circulating cytokine levels in ALK(+)ALCL patients and detected elevated levels of IL-22, IL-17, and IL-8 in untreated patient samples. Importantly, IL-22 and IL-17 were undetectable in all patients who were in complete remission after chemotherapy. This study documents a previously unknown role of IL-22R1 in inflammation and identifies the involvement of IL-22R1/IL-22 in ALK(+)ALCL.

摘要

白细胞介素 (IL)-22R1 链是二聚体 IL-22 受体的一部分,在正常白细胞中不表达,但在间变性淋巴瘤激酶阳性 (ALK(+))间变性大细胞淋巴瘤 (ALCL) 患者的 T 细胞中表达。为了研究这种受体在淋巴细胞上异常表达的后果,我们生成了在淋巴细胞上表达 IL-22R1 的转基因小鼠。这些动物的健康状况在 8 至 12 周龄时逐渐恶化,表现为呼吸困难、毛发粗糙和行动迟缓,随后由于多器官炎症而死亡。IL-22R1 转基因动物出现中性粒细胞增多,与循环中 IL-17 和粒细胞集落刺激因子水平升高相关。此外,这些小鼠的血清 IL-22 水平升高,表明表达 IL-22R1 的 T 细胞在正反馈环中产生 IL-22。基于小鼠模型的研究结果,我们分析了 ALK(+)ALCL 患者的循环细胞因子水平,并在未经治疗的患者样本中检测到 IL-22、IL-17 和 IL-8 的水平升高。重要的是,在所有化疗后完全缓解的患者中,均未检测到 IL-22 和 IL-17。本研究证明了 IL-22R1 在炎症中的一个未知作用,并确定了 IL-22R1/IL-22 在 ALK(+)ALCL 中的参与。

相似文献

1
A novel role for IL-22R1 as a driver of inflammation.IL-22R1 在炎症中的新型驱动作用
Blood. 2011 Jan 13;117(2):575-84. doi: 10.1182/blood-2010-05-285908. Epub 2010 Oct 22.
2
Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma.IL-22受体1的异常表达和自分泌IL-22刺激促成ALK阳性间变性大细胞淋巴瘤的致瘤性。
Leukemia. 2008 Aug;22(8):1595-603. doi: 10.1038/leu.2008.129. Epub 2008 May 29.
3
IL-21 contributes to JAK3/STAT3 activation and promotes cell growth in ALK-positive anaplastic large cell lymphoma.白细胞介素-21有助于JAK3/STAT3激活,并促进ALK阳性间变性大细胞淋巴瘤中的细胞生长。
Am J Pathol. 2009 Aug;175(2):825-34. doi: 10.2353/ajpath.2009.080982. Epub 2009 Jul 16.
4
Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma.鉴定间变性淋巴瘤激酶 (ALK)+和 ALK-间变性大细胞淋巴瘤中差异表达和具有功能活性的 microRNA。
Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16228-33. doi: 10.1073/pnas.1009719107. Epub 2010 Aug 30.
5
Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation.miR-155在缺乏t(2;5)易位的间变性大细胞淋巴瘤中的致癌作用。
J Pathol. 2015 Aug;236(4):445-56. doi: 10.1002/path.4539. Epub 2015 Apr 27.
6
Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target.核仁磷酸蛋白-间变性淋巴瘤激酶:终极致癌基因和治疗靶点。
Blood. 2017 Feb 16;129(7):823-831. doi: 10.1182/blood-2016-05-717793. Epub 2016 Nov 22.
7
Human IL-22 receptor-targeted small protein antagonist suppress murine DSS-induced colitis.靶向人白细胞介素-22受体的小分子蛋白拮抗剂可抑制小鼠葡聚糖硫酸钠诱导的结肠炎。
Cell Commun Signal. 2024 Oct 1;22(1):469. doi: 10.1186/s12964-024-01846-w.
8
ALK+ALCLs induce cutaneous, HMGB-1-dependent IL-8/CXCL8 production by keratinocytes through NF-κB activation.ALK+ALCLs 通过激活 NF-κB 诱导角质形成细胞产生皮肤型、HMGB-1 依赖性的白细胞介素-8/CXCL8。
Blood. 2012 May 17;119(20):4698-707. doi: 10.1182/blood-2011-10-386011. Epub 2012 Mar 6.
9
Analysis and therapeutic targeting of the IL-1R pathway in anaplastic large cell lymphoma.间变大细胞淋巴瘤中白介素-1 受体通路的分析与治疗靶点。
Blood. 2023 Oct 12;142(15):1297-1311. doi: 10.1182/blood.2022019166.
10
STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma.STAT1 被致癌酪氨酸激酶 NPM-ALK 在 ALK 阳性间变大细胞淋巴瘤中磷酸化和下调。
Blood. 2015 Jul 16;126(3):336-45. doi: 10.1182/blood-2014-10-603738. Epub 2015 Apr 28.

引用本文的文献

1
Tumour-associated myeloid cells expressing IL-10R2/IL-22R1 as a potential biomarker for diagnosis and recurrence of pancreatic ductal adenocarcinoma.表达 IL-10R2/IL-22R1 的肿瘤相关髓系细胞作为胰腺导管腺癌诊断和复发的潜在生物标志物。
Br J Cancer. 2024 Jun;130(12):1979-1989. doi: 10.1038/s41416-024-02676-w. Epub 2024 Apr 20.
2
Germline mechanisms of immunotherapy toxicities in the era of genome-wide association studies.免疫治疗毒性的胚系机制研究在全基因组关联研究时代。
Immunol Rev. 2023 Sep;318(1):138-156. doi: 10.1111/imr.13253. Epub 2023 Jul 28.
3
IL-4, IL-13 and IFN-γ -induced genes in highly purified human neutrophils.高纯度人嗜中性粒细胞中 IL-4、IL-13 和 IFN-γ 诱导的基因。
Cytokine. 2023 Apr;164:156159. doi: 10.1016/j.cyto.2023.156159. Epub 2023 Feb 19.
4
The role of interleukin-22 in lung health and its therapeutic potential for COVID-19.白细胞介素-22 在肺部健康中的作用及其在 COVID-19 治疗中的潜力。
Front Immunol. 2022 Jul 27;13:951107. doi: 10.3389/fimmu.2022.951107. eCollection 2022.
5
IL22RA1/JAK/STAT Signaling Acts As a Cancer Target Through Pan-Cancer Analysis.IL22RA1/JAK/STAT 信号通过泛癌分析作为癌症靶点。
Front Immunol. 2022 Jul 8;13:915246. doi: 10.3389/fimmu.2022.915246. eCollection 2022.
6
Distinct Expression Patterns of Interleukin-22 Receptor 1 on Blood Hematopoietic Cells in SARS-CoV-2 Infection.新型冠状病毒感染中白细胞介素-22受体1在血液造血细胞上的独特表达模式
Front Immunol. 2022 Mar 29;13:769839. doi: 10.3389/fimmu.2022.769839. eCollection 2022.
7
Cytokines, Genetic Lesions and Signaling Pathways in Anaplastic Large Cell Lymphomas.间变性大细胞淋巴瘤中的细胞因子、基因损伤与信号通路
Cancers (Basel). 2021 Aug 24;13(17):4256. doi: 10.3390/cancers13174256.
8
Primary Sjogren Syndrome: Focus on Innate Immune Cells and Inflammation.原发性干燥综合征:聚焦于固有免疫细胞与炎症
Vaccines (Basel). 2020 Jun 3;8(2):272. doi: 10.3390/vaccines8020272.
9
Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.起源细胞和免疫事件在乳腺植入物相关间变大细胞淋巴瘤的发病机制中的作用。
Am J Pathol. 2020 Jan;190(1):2-10. doi: 10.1016/j.ajpath.2019.09.005. Epub 2019 Oct 11.
10
Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma.依赖于 TYK2/STAT1/MCL1 轴的间变大细胞淋巴瘤。
Leukemia. 2019 Mar;33(3):696-709. doi: 10.1038/s41375-018-0239-1. Epub 2018 Aug 21.

本文引用的文献

1
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma.改善外周 T 细胞淋巴瘤诊断和血管免疫母细胞性 T 细胞淋巴瘤预后的分子标志物。
Blood. 2010 Feb 4;115(5):1026-36. doi: 10.1182/blood-2009-06-227579. Epub 2009 Nov 18.
2
IL-21 contributes to JAK3/STAT3 activation and promotes cell growth in ALK-positive anaplastic large cell lymphoma.白细胞介素-21有助于JAK3/STAT3激活,并促进ALK阳性间变性大细胞淋巴瘤中的细胞生长。
Am J Pathol. 2009 Aug;175(2):825-34. doi: 10.2353/ajpath.2009.080982. Epub 2009 Jul 16.
3
Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.自分泌白细胞介素-22的抗凋亡活性及白细胞介素-22小干扰RNA对人肺癌异种移植瘤的治疗作用
Clin Cancer Res. 2008 Oct 15;14(20):6432-9. doi: 10.1158/1078-0432.CCR-07-4401.
4
Structure of IL-22 bound to its high-affinity IL-22R1 chain.与高亲和力IL-22R1链结合的IL-22结构
Structure. 2008 Sep 10;16(9):1333-44. doi: 10.1016/j.str.2008.06.005. Epub 2008 Jul 3.
5
Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma.IL-22受体1的异常表达和自分泌IL-22刺激促成ALK阳性间变性大细胞淋巴瘤的致瘤性。
Leukemia. 2008 Aug;22(8):1595-603. doi: 10.1038/leu.2008.129. Epub 2008 May 29.
6
Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers.剂量调整的EPOCH与利妥昔单抗治疗初治弥漫性大B细胞淋巴瘤的II期研究及生发中心和生发中心后生物标志物分析
J Clin Oncol. 2008 Jun 1;26(16):2717-24. doi: 10.1200/JCO.2007.13.1391. Epub 2008 Mar 31.
7
The anaplastic lymphoma kinase in the pathogenesis of cancer.间变性淋巴瘤激酶在癌症发病机制中的作用
Nat Rev Cancer. 2008 Jan;8(1):11-23. doi: 10.1038/nrc2291.
8
IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner.白细胞介素-21由辅助性T细胞17(Th17细胞)产生,并以信号转导和转录激活因子3(STAT3)依赖的方式驱动白细胞介素-17的产生。
J Biol Chem. 2007 Nov 30;282(48):34605-10. doi: 10.1074/jbc.M705100200. Epub 2007 Sep 20.
9
Extreme neutrophil granulocytosis in a patient with anaplastic large cell lymphoma of T-cell lineage.一名T细胞系间变性大细胞淋巴瘤患者出现极度中性粒细胞增多症。
APMIS. 2007 Jun;115(6):778-83. doi: 10.1111/j.1600-0463.2007.apm_585.x.
10
Effective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1.用放射性标记的抗CD30抗体HeFi-1对人类白血病和淋巴瘤小鼠模型进行有效治疗。
Proc Natl Acad Sci U S A. 2007 May 15;104(20):8444-8. doi: 10.1073/pnas.0702496104. Epub 2007 May 8.